Cas No.: | 1458664-10-2 |
Chemical Name: | beta-Catenin-IN-2 |
Synonyms: | beta-catenin-IN-2;4-(6-Fluoro-1H-benzo[d]imidazol-2-yl)-N,N-dimethylaniline;β-catenin-IN-2 |
SMILES: | FC1C([H])=C([H])C2=C(C=1[H])N([H])C(C1C([H])=C([H])C(=C([H])C=1[H])N(C([H])([H])[H])C([H])([H])[H])=N2 |
Formula: | C15H14FN3 |
M.Wt: | 255.2902 |
Purity: | >98% |
Sotrage: | Powder-20°C3 years4°C2 yearsIn solvent-80°C6 months -20°C1 month |
Description: | β-catenin-IN-2 is a potent β-catenin inhibitor, compound H1B1, extracted from patent US20150374662A1. β-catenin-IN-2 can be used for the study of colorectal cancer. |
In Vitro: | β-catenin-IN-2 (10-40 μM) suppresses the transcriptional activity of the β-catenin/Tcf-4 in a dose-dependent manner in HCT116 cells[1]. |
References: | [1]. Ann Marie Bode, et al. Inhibitors of beta-catenin in treatment of colorectal cancer. Patent US20150374662A1. |